pH-Sensitive Long-Circulating Nanoliposomes with CU1 for Effective Against Lung Cancer

Area of Science:

• Nanomedicine
• Drug Delivery Systems
• Cancer Therapeutics

Background:

• Curcumin derivative CU1 suffers from poor water solubility and low bioavailability.
• Effective delivery systems are crucial for enhancing the therapeutic potential of poorly soluble drugs.

Purpose of the Study:

• To develop and evaluate a long-circulating pH-sensitive nanoliposome (CU1-LCpHL) for improved delivery of CU1.
• To assess the anti-lung cancer efficacy of CU1-LCpHL both in vitro and in vivo.

Main Methods:

• Construction and characterization of CU1-LCpHL.
• In vitro evaluation of cellular uptake, apoptosis, proliferation, and migration.
• In vivo pharmacokinetic and pharmacodynamic studies.
• Mechanistic investigations and immunohistochemical analysis.

Main Results:

• CU1-LCpHL exhibited favorable physicochemical properties, stability, and sustained-release characteristics.
• In vitro studies showed enhanced cellular uptake and significant inhibition of lung cancer cell proliferation and migration by CU1-LCpHL.
• In vivo studies demonstrated significantly improved pharmacokinetics, pharmacodynamics, and tumor inhibition rates with CU1-LCpHL compared to controls, with no observed toxicity.

Conclusions:

• CU1-LCpHL effectively enhances the delivery efficiency and antitumor efficacy of CU1.
• This nanoliposome formulation represents a promising nano-drug delivery system for lung cancer therapy.